Cite
Inchingolo AD, Inchingolo AM, Bordea IR, et al. SARS-CoV-2 Disease Adjuvant Therapies and Supplements Breakthrough for the Infection Prevention. Microorganisms. 2021;9(3)doi: 10.3390/microorganisms9030525.
Inchingolo, A. D., Inchingolo, A. M., Bordea, I. R., Malcangi, G., Xhajanka, E., Scarano, A., Lorusso, F., Farronato, M., Tartaglia, G. M., Isacco, C. G., Marinelli, G., D'Oria, M. T., Hazballa, D., Santacroce, L., Ballini, A., Contaldo, M., Inchingolo, F., & Dipalma, G. (2021). SARS-CoV-2 Disease Adjuvant Therapies and Supplements Breakthrough for the Infection Prevention. Microorganisms, 9(3), . https://doi.org/10.3390/microorganisms9030525
Inchingolo, Alessio Danilo, et al. "SARS-CoV-2 Disease Adjuvant Therapies and Supplements Breakthrough for the Infection Prevention." Microorganisms vol. 9,3 (2021). doi: https://doi.org/10.3390/microorganisms9030525
Inchingolo AD, Inchingolo AM, Bordea IR, Malcangi G, Xhajanka E, Scarano A, Lorusso F, Farronato M, Tartaglia GM, Isacco CG, Marinelli G, D'Oria MT, Hazballa D, Santacroce L, Ballini A, Contaldo M, Inchingolo F, Dipalma G. SARS-CoV-2 Disease Adjuvant Therapies and Supplements Breakthrough for the Infection Prevention. Microorganisms. 2021 Mar 04;9(3). doi: 10.3390/microorganisms9030525. PMID: 33806624; PMCID: PMC7999785.
Copy
Download .nbib